Work

Treatment of Idiopathic Pulmonary Fibrosis with a New Antifibrotic Agent, Pirfenidone: Results of a Prospective, Open-label Phase II Study

FWCI: 17.04
Cites: 30
Cited by: 472
Related to: 7